The effect of clofibrate on plasma factor and vascular prostacyclin-synthesis.
D000328:Adult; D000818:Animals; D001011:Aorta / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism*; D002994:Clofibrate / Q000494:pharmacology*; D004036:Diet, Atherogenic; D011464:Epoprostenol / Q000096:biosynthesis*; D006801:Humans; D006953:Hyperlipoproteinemia Type IV / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D010978:Platelet Factor 4 / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis*; D011817:Rabbits; D013552:Swine; D013556:Swine, Miniature; D014680:Veins / Q000378:metabolism
D011453:Prostaglandins; D010978:Platelet Factor 4; D011464:Epoprostenol; D002994:Clofibrate